KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - NetReceivables - OtherShares Issued
Ratios

Gilead Sciences (GILD) Leases (2019 - 2025)

Gilead Sciences' Leases history spans 10 years, with the latest figure at $532.0 million for Q4 2025.

  • For Q4 2025, Leases rose 3.3% year-over-year to $532.0 million; the TTM value through Dec 2025 reached $532.0 million, up 3.3%, while the annual FY2025 figure was $532.0 million, 3.3% up from the prior year.
  • Leases reached $532.0 million in Q4 2025 per GILD's latest filing, up from $515.0 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $581.0 million in Q4 2023 to a low of $505.0 million in Q4 2022.
  • Average Leases over 5 years is $535.0 million, with a median of $532.0 million recorded in 2025.
  • Peak YoY movement for Leases: decreased 16.1% in 2021, then rose 15.05% in 2023.
  • A 5-year view of Leases shows it stood at $542.0 million in 2021, then fell by 6.83% to $505.0 million in 2022, then increased by 15.05% to $581.0 million in 2023, then dropped by 11.36% to $515.0 million in 2024, then rose by 3.3% to $532.0 million in 2025.
  • Per Business Quant, the three most recent readings for GILD's Leases are $532.0 million (Q4 2025), $515.0 million (Q4 2024), and $581.0 million (Q4 2023).